✦ LIBER ✦

Alzheimer's disease biomarkers as outcome measures for clinical trials

✍ Scribed by Caroli, Anna; Prestia, Annapaola; Wade, Sara; Chen, Kewei; Ayutyanont, Napatkamon; Landau, Susan; Madison, Cindee; Haense, Cathleen; Herholz, Karl; Reiman, Eric; Jagust, William; Frisoni, Giovanni

Book ID: 122379142
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 9
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.05.1455

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CSF biomarkers as outcome measures in cl

CSF biomarkers as outcome measures in clinical trials

✍ Douglas Galasko 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Associative and item memory as outcome m

Associative and item memory as outcome measures for Alzheimer’s disease clinical trials: A pilot study

✍ Andrew E. Budson; Hyemi Chong; Lisa M. Sardinha; Sibyl Salisbury; Dorene M. Rent 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Scales as outcome measures for Alzheimer

Scales as outcome measures for Alzheimer's disease

✍ Ronald Black; Barry Greenberg; J. Michael Ryan; Holly Posner; Jeffrey Seeburger; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 289 KB

Biomarker utility in Alzheimer's disease

Biomarker utility in Alzheimer's disease clinical trials

✍ Soares, Holly D.; Lovestone, Simon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 345 KB

Neuroimaging biomarkers for clinical tri

Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer’s disease

✍ Dickerson, Bradford C. ;Sperling, Reisa A. 📂 Article 📅 2005 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 273 KB

Biological and Imaging markers as outcom

Biological and Imaging markers as outcome measures for secondary prevention trials in Alzheimer's disease

✍ H. Hampel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 58 KB